US5856091A
(en)
*
|
1993-03-18 |
1999-01-05 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
|
US6660276B1
(en)
|
1994-02-16 |
2003-12-09 |
The University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
|
EP0668350B2
(en)
*
|
1994-02-16 |
2008-12-03 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
EP1630229B1
(en)
*
|
1994-04-22 |
2013-04-03 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Melanoma antigens
|
DE69723230T2
(de)
*
|
1996-01-17 |
2004-05-27 |
Imperial College Innovations Ltd. |
Immunotherapie mit verwendung von zytotoxischen t lymphozyten (ctl)
|
US7015312B1
(en)
*
|
1996-02-09 |
2006-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof
|
US20040156861A1
(en)
*
|
1996-07-11 |
2004-08-12 |
Figdor Carl Gustav |
Melanoma associated peptide analogues and vaccines against melanoma
|
US20020155093A1
(en)
*
|
1997-02-18 |
2002-10-24 |
Houghton Alan N. |
Method for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
|
EP1012173B1
(en)
*
|
1997-06-23 |
2007-10-31 |
Ludwig Institute For Cancer Research |
Isolated decapeptides which bind to hla molecules, and the use thereof
|
US6025470A
(en)
*
|
1997-06-23 |
2000-02-15 |
Ludwig Institute For Cancer Research |
Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
|
US6872518B2
(en)
*
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
AU1628599A
(en)
*
|
1997-12-05 |
1999-06-28 |
Medical College Of Georgia Research Institute, Inc. |
Regulation of t cell-mediated immunity by tryptophan
|
US20030138808A1
(en)
*
|
1998-02-19 |
2003-07-24 |
Simard John J.L. |
Expression vectors encoding epitopes of target-associated antigens
|
EP1071325A4
(en)
*
|
1998-03-20 |
2004-12-22 |
Genzyme Corp |
COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
|
US6465180B1
(en)
*
|
1999-03-17 |
2002-10-15 |
The Regents Of The University Of California |
Detection of premalignant melanocytes
|
GB9908263D0
(en)
*
|
1999-04-13 |
1999-06-02 |
Binding Site The Limited |
Eliciting improved immune responses
|
EP1187849A1
(en)
*
|
1999-05-25 |
2002-03-20 |
Human Genome Sciences, Inc. |
Meth1 and meth2 polynucleotides and polypeptides
|
AU7917200A
(en)
*
|
1999-09-30 |
2001-04-30 |
Institut Pasteur |
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences
|
GB9924351D0
(en)
|
1999-10-14 |
1999-12-15 |
Brennan Frank |
Immunomodulation methods and compositions
|
WO2001030847A1
(en)
|
1999-10-22 |
2001-05-03 |
Aventis Pasteur Limited |
Modified gp100 and uses thereof
|
EP1268542A2
(en)
*
|
2000-03-20 |
2003-01-02 |
Genzyme Corporation |
Therapeutic anti-melanoma compounds
|
FR2806727A1
(fr)
*
|
2000-03-23 |
2001-09-28 |
Pf Medicament |
Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
|
EP1268763A2
(en)
*
|
2000-03-28 |
2003-01-02 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
DE60142615D1
(de)
*
|
2000-04-28 |
2010-09-02 |
Mannkind Corp |
Epitop-synchronisierung in antigen präsentierenden zellen
|
US20030215425A1
(en)
*
|
2001-12-07 |
2003-11-20 |
Simard John J. L. |
Epitope synchronization in antigen presenting cells
|
AU5810201A
(en)
*
|
2000-05-10 |
2001-11-20 |
Aventis Pasteur |
Immunogenic polypeptides encoded by mage minigenes and uses thereof
|
CA2411040A1
(en)
*
|
2000-05-31 |
2001-12-06 |
Genzyme Corporation |
Therapeutic anti-melanoma compounds
|
EP1305336A2
(en)
*
|
2000-08-04 |
2003-05-02 |
Genzyme Corporation |
Therapeutic anti-melanoma compounds
|
US20020177547A1
(en)
*
|
2001-01-16 |
2002-11-28 |
Karin Molling |
Pharmaceutical compositions for treating or preventing cancer
|
EP1222928A3
(en)
*
|
2001-01-16 |
2003-11-05 |
Universität Zürich Institut für Medizinische Virologie |
Pharmaceutical compositions for treating or preventing cancer, especially melanoma
|
JP2005503118A
(ja)
*
|
2001-02-14 |
2005-02-03 |
ジェンザイム・コーポレーション |
改変ペプチドリガンド
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
EA013944B1
(ru)
*
|
2001-02-20 |
2010-08-30 |
Орто-Макнейл Фармасьютикал, Инк. |
Способ получения неприродной антигенпрезентирующей клеточной линии и применение линии для лечения опухолей
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
CN1280307C
(zh)
*
|
2001-04-03 |
2006-10-18 |
宝生物工程株式会社 |
细胞毒性t淋巴细胞
|
WO2003008537A2
(en)
*
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
EP1752160A3
(en)
|
2001-04-06 |
2007-05-30 |
Mannkind Corporation |
Epitope sequences
|
AU2002305138A1
(en)
*
|
2001-04-09 |
2002-10-21 |
Mayo Foundation For Medical Education And Research |
Methods and materials for cancer treatment
|
MXPA03010507A
(es)
*
|
2001-05-15 |
2005-07-25 |
Johnson & Johnson |
Activacion ex vivo para generar linfocitos c citotoxicos espedificos para antigenos no tumorales para tratar enfermedades autoinmunes y alergicas.
|
US20080220015A1
(en)
*
|
2001-08-03 |
2008-09-11 |
Nokad, S.A. |
Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal trangenesis and in functional inactivation of endogenous proteins
|
US20030113919A1
(en)
*
|
2001-08-17 |
2003-06-19 |
Aventis Pasteur, Ltd. |
Immunogenic targets for melanoma
|
AU2002331704A1
(en)
*
|
2001-08-22 |
2003-03-10 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health A |
Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
|
CN1313617C
(zh)
*
|
2001-11-07 |
2007-05-02 |
曼康公司 |
编码靶相关抗原表位的表达载体及其设计方法
|
US6783944B2
(en)
|
2002-01-04 |
2004-08-31 |
The Regents Of The University Of California |
Genetic changes in atypical nodular proliferations in congenital melanocytic nevi
|
DE10229872A1
(de)
*
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
US20040018622A1
(en)
*
|
2002-07-17 |
2004-01-29 |
Mitchell Lloyd G. |
Spliceosome mediated RNA trans-splicing for correction of skin disorders
|
US20040223949A1
(en)
*
|
2002-10-22 |
2004-11-11 |
Sunnybrook And Women's College Health Sciences Center Aventis Pasteur, Ltd. |
Vaccines using high-dose cytokines
|
EP1605973B1
(en)
*
|
2003-03-26 |
2012-09-26 |
Cytos Biotechnology AG |
Packaging of immunostimulatory oligonucleotides into virus-like particles: methods of preparation and uses
|
US7537767B2
(en)
*
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
US20060210588A1
(en)
*
|
2003-03-26 |
2006-09-21 |
Cytos Biotechnology Ag |
Hiv-peptide-carrier-conjugates
|
US7598287B2
(en)
|
2003-04-01 |
2009-10-06 |
Medical College Of Georgia Research Institute, Inc. |
Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
|
US20050186289A1
(en)
*
|
2003-04-01 |
2005-08-25 |
Medical College Of Georgia Research Institute, Inc. |
Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase
|
US7178491B2
(en)
*
|
2003-06-05 |
2007-02-20 |
Caterpillar Inc |
Control system and method for engine valve actuator
|
AU2004253465A1
(en)
|
2003-06-11 |
2005-01-13 |
The University Of Chicago |
Increased T-cell tumor infiltration by mutant light
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
ATE546153T1
(de)
*
|
2003-06-17 |
2012-03-15 |
Mannkind Corp |
Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
EP1670513B1
(en)
*
|
2003-10-06 |
2013-01-23 |
Cedars-Sinai Medical Center |
Cox-2 inhibitors and dendritic cells for use in the treatment of cancer.
|
US20080038838A1
(en)
*
|
2003-10-10 |
2008-02-14 |
Towa Kagaku Co., Ltd. |
Dioxin-Binding Material and Method of Detecting or Quantifying Dioxin
|
CN1894587A
(zh)
*
|
2003-10-29 |
2007-01-10 |
财团法人熊本高新技术产业财团 |
恶性黑色素瘤(melanoma)的诊断试剂
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
KR20070056042A
(ko)
*
|
2004-06-17 |
2007-05-31 |
맨카인드 코포레이션 |
에피토프 유사체
|
US20060159689A1
(en)
*
|
2004-06-17 |
2006-07-20 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
US20060008468A1
(en)
*
|
2004-06-17 |
2006-01-12 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
US20070154889A1
(en)
*
|
2004-06-25 |
2007-07-05 |
Veridex, Llc |
Methods and reagents for the detection of melanoma
|
WO2006037059A2
(en)
|
2004-09-27 |
2006-04-06 |
The Johns Hopkins Universtiy |
Point-of-care mass spectrometer system
|
WO2006071983A2
(en)
|
2004-12-29 |
2006-07-06 |
Mannkind Corporation |
Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
|
AU2005321904B2
(en)
*
|
2004-12-29 |
2012-07-12 |
Mannkind Corporation |
Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes
|
WO2006138449A2
(en)
*
|
2005-06-16 |
2006-12-28 |
The Wistar Institute |
Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
|
KR20080028938A
(ko)
|
2005-06-17 |
2008-04-02 |
맨카인드 코포레이션 |
에피토프 유사체
|
JP5416968B2
(ja)
|
2005-06-17 |
2014-02-12 |
マンカインド コーポレイション |
癌細胞及び腫瘍間質上に発現される優勢及び亜優勢エピトープに対する多価免疫応答を誘発するための方法及び組成物
|
BRPI0611795A2
(pt)
|
2005-06-17 |
2010-09-28 |
Mannkind Corp |
imunoterapêutica arrastar-e-amplificar multivalente para carcinoma
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
US20070178113A1
(en)
*
|
2005-11-22 |
2007-08-02 |
Backstrom B T |
Superantigen conjugate
|
AU2007280690C1
(en)
|
2006-07-31 |
2012-08-23 |
Curevac Gmbh |
Nucleic acid of formula (I): GIXmGn, or (II): CIXmCn, in particular as an immune-stimulating agent/adjuvant
|
DE102006035618A1
(de)
*
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
Nukleinsäure der Formel (I): GlXmGn, insbesondere als immunstimulierendes Adjuvanz
|
EP2084267B1
(en)
*
|
2006-09-26 |
2018-04-11 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
US8097256B2
(en)
|
2006-09-28 |
2012-01-17 |
Cedars-Sinai Medical Center |
Cancer vaccines and vaccination methods
|
WO2008098183A2
(en)
*
|
2007-02-08 |
2008-08-14 |
The University Of Chicago |
Combination therapy for treating cancer
|
ES2433967T3
(es)
|
2007-05-14 |
2013-12-13 |
The University Of Chicago |
Productos de fusión anticuerpo-LIGHT como productos terapéuticos de cáncer
|
WO2008148068A1
(en)
*
|
2007-05-23 |
2008-12-04 |
Mannkind Corporation |
Multicistronic vectors and methods for their design
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
CN101827613A
(zh)
|
2007-09-27 |
2010-09-08 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
EP2548960B1
(en)
|
2008-01-31 |
2018-01-31 |
CureVac AG |
Nucleic acids comprising formula (nugixmgnv)a and derivatives thereof as an immunostimulating agents/adjuvant
|
EP2296696B1
(en)
|
2008-06-05 |
2014-08-27 |
ImmunoVaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
US9068020B2
(en)
*
|
2008-09-02 |
2015-06-30 |
Cedars-Sinai Medical Center |
CD133 epitopes
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
AU2009308707A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
CA2750922A1
(en)
*
|
2009-01-28 |
2010-08-05 |
Antigen Express, Inc. |
Li-key hybrid peptides that modulate the immune response to influenza
|
ES2618573T3
(es)
*
|
2009-05-07 |
2017-06-21 |
ImmunoCellular Therapeutics,Ltd |
Epítopos de CD133
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
AU2010310468A1
(en)
|
2009-10-23 |
2012-05-24 |
Mannkind Corporation |
Cancer immunotherapy and method of treatment
|
EP3450979A3
(en)
|
2010-03-17 |
2019-04-24 |
The Regents of The University of Michigan |
Using phage epitopes to profile the immune response
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
SG186706A1
(en)
|
2010-07-30 |
2013-02-28 |
Curevac Gmbh |
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
|
US9040046B2
(en)
|
2011-01-31 |
2015-05-26 |
Kai Xu |
Sodium pump antibody agonists and methods of treating heart disease using the same
|
AU2012321022B2
(en)
|
2011-10-06 |
2017-03-23 |
Immunovaccine Technologies Inc. |
Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
|
CN105288602A
(zh)
*
|
2011-10-20 |
2016-02-03 |
新干细胞肿瘤学有限责任公司 |
具有γ干扰素的抗原呈递癌症疫苗
|
WO2013090293A1
(en)
|
2011-12-15 |
2013-06-20 |
The University Of Chicago |
Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
EP2869828B1
(en)
|
2012-07-09 |
2018-01-03 |
The Regents of The University of California |
Vault immunotherapy
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
EP2970369B1
(en)
|
2013-03-14 |
2023-11-22 |
TheraSyn Sensors, Inc. |
Cholestosome vesicles for incorporation of molecules into chylomicrons
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
AU2014310934B2
(en)
|
2013-08-21 |
2019-09-12 |
CureVac SE |
Respiratory syncytial virus (RSV) vaccine
|
WO2015149944A2
(en)
|
2014-04-01 |
2015-10-08 |
Curevac Gmbh |
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
|
CN110418636A
(zh)
*
|
2016-08-23 |
2019-11-05 |
杰罗米.J.申塔格 |
将肽、蛋白质和核酸负载至乳糜微粒和体细胞中的胆固醇酯囊泡
|
WO2018165631A1
(en)
*
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
AU2021267940A1
(en)
|
2020-05-08 |
2022-12-08 |
President And Fellows Of Harvard College |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|